John H. Growdon

John H. Growdon
Founding Director, Massachusetts Alzheimer’s Disease Research Center & MGH Memory Disorders Unit, Director, MGH Movement Disorders Unit, Massachusetts General Hospital, Professor of Neurology, Harvard Medical School
Massachusetts General Hospital, Harvard Medical School
(617) 726-1729
Neurology and neuropharmacology of neurodegenerative disease, especially Alzheimer and Parkinson diseases
More Information: Growdon Profile

John Growdon is Professor of Neurology at the Harvard Medical School and attending neurologist at the Massachusetts General Hospital. He graduated from Northwestern University in 1960 with a BA in English Literature and obtained the MD degree from the University of Pennsylvania in 1965. His post-graduate training was in Internal Medicine at the University of Chicago Hospitals (1965-69), in Neurology at the Massachusetts General Hospital (1971-74) and in Neurochemistry at the Massachusetts Institute of Technology (1975-1977). Since 1982, he has directed the Memory and Movement Disorders Units at the Massachusetts General Hospital, which provide diagnostic services and continuing care for individuals with Parkinson disease and related movement disorders, and for individuals with cognitive impairments and dementia, including Alzheimer disease.
Dr. Growdon founded the Massachusetts Alzheimer’s Disease Research Center funded by the National Institute on Aging and currently serves as the Director of the Memory Disorders Unit, which is the clinical arm of the Center. He is also Director of the Movement Disorders Unit, which is the clinical unit for the MGH Udall Center of Excellence for Parkinson Disease Research funded by the National Institute for Neurologic Diseases and Stroke. His research interests center on the clinical neurology and neuropharmacology of Alzheimer and Parkinson diseases, along with efforts to uncover biologic markers of these disease that could lead to improved diagnostic accuracy and treatment.

Atri A, Shaughnessy LW, Locascio JJ, Growdon JH. Long-Term Course and Effectiveness of Combination Therapy in Alzheimer Disease. Alzheimer Dis Assoc Disord 2008; 22:  209-222. [PMCID:  2718545].
Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson, KA. Imaging Amyloid Deposition in Lewy Body Disease. Neurology 2008; 71:  903-910. [PMCID:  2637553].
More publications may be found at www.ncbi.nlm.nih.gov/